As of 2024-12-11, the Relative Valuation of Active Biotech AB (publ) (ACTI.ST) is (1.08) SEK. This relative valuation is based on P/E multiples. With the latest stock price at 0.11 SEK, the upside of Active Biotech AB (publ) based on Relative Valuation is -1046.4%.
The range of the Relative Valuation is (0.87) - (1.13) SEK.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 23.3x - 30.9x | 30.7x |
| Forward P/E multiples | 21.1x - 30.4x | 27.0x |
| Fair Price | (0.87) - (1.13) | (1.08) |
| Upside | -865.6% - -1095.9% | -1046.4% |
| Date | P/E |
| 2024-12-09 | -3.38 |
| 2024-12-06 | -3.37 |
| 2024-12-05 | -3.47 |
| 2024-12-04 | -3.41 |
| 2024-12-03 | -3.86 |
| 2024-12-02 | -4.03 |
| 2024-11-29 | -7.22 |
| 2024-11-28 | -6.82 |
| 2024-11-27 | -6.94 |
| 2024-11-26 | -6.90 |
| 2024-11-25 | -6.61 |
| 2024-11-22 | -6.71 |
| 2024-11-21 | -6.87 |
| 2024-11-20 | -7.51 |
| 2024-11-19 | -8.05 |
| 2024-11-18 | -6.02 |
| 2024-11-15 | -6.83 |
| 2024-11-14 | -7.84 |
| 2024-11-13 | -7.81 |
| 2024-11-12 | -4.42 |
| 2024-11-11 | -4.62 |
| 2024-11-08 | -5.20 |
| 2024-11-07 | -4.43 |
| 2024-11-06 | -4.35 |
| 2024-11-05 | -4.48 |
| 2024-11-04 | -4.29 |
| 2024-11-01 | -4.83 |
| 2024-10-31 | -5.07 |
| 2024-10-30 | -6.31 |
| 2024-10-29 | -7.15 |
| 2024-10-28 | -7.51 |
| 2024-10-25 | -9.66 |
| 2024-10-24 | -3.42 |
| 2024-10-23 | -3.62 |
| 2024-10-22 | -3.49 |
| 2024-10-21 | -7.66 |
| 2024-10-18 | -7.90 |
| 2024-10-17 | -7.92 |
| 2024-10-16 | -8.04 |
| 2024-10-15 | -8.04 |
| 2024-10-14 | -8.18 |
| 2024-10-11 | -7.78 |
| 2024-10-10 | -7.81 |
| 2024-10-09 | -7.94 |
| 2024-10-08 | -8.05 |
| 2024-10-07 | -8.05 |
| 2024-10-04 | -8.05 |
| 2024-10-03 | -8.37 |
| 2024-10-02 | -8.18 |
| 2024-10-01 | -8.20 |